SUBSCRIBE
SUBSCRIBE

bluebird bio

NEWS
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
LentiGlobin Looks Promising On Sickle Cell For bluebird bio, Says Analyst
November 19, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
bluebird bio To Present At Investor Conferences In September
September 1, 2017
 · 
2 min read
bluebird bio Reports Second Quarter 2017 Financial Results And Recent Operational Progress
August 3, 2017
 · 
8 min read
bluebird bio Eyes $350 Million Public Offering of Common Stock
June 28, 2017
 · 
5 min read
bluebird bio Announces Topline Interim Clinical Data From Starbeam Study Of Lenti-D Drug Product In Cerebral Adrenoleukodystrophy (CALD)
June 27, 2017
 · 
7 min read
bluebird bio Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting
June 23, 2017
 · 
10 min read
bluebird bio Announces Early Data From Phase III Northstar-2 (HGB-207) Study Of LentiGlobin Drug Product At European Hematology Association Annual Meeting
June 23, 2017
 · 
7 min read
bluebird bio Appoints John O. Agwunobi, M.D. And Douglas A. Melton, Ph.D. To Board Of Directors
June 9, 2017
 · 
5 min read
bluebird bio Announces Collaboration With Duke University’s Robert J. Margolis, MD, Center For Health Policy On Value-Based Payment Framework For Gene Therapy
May 23, 2017
 · 
4 min read
bluebird bio To Present New Data From Lentiglobintm Clinical Studies At European Hematology Association (EHA) Annual Meeting
May 18, 2017
 · 
5 min read
bluebird bio Reports First Quarter 2017 Financial Results And Recent Operational Progress
May 4, 2017
 · 
1 min read